RedShiftBio provides an infrared technology with advanced data analytics to facilitate better, faster decision making in biopharmaceutical development from discovery to market via the direct measurement of previously undetectable change in protein structural attributes critical to drug product efficacy and quality. It has developed a MicrofluidicModulation Spectroscopy (MMS) platform in response to a customer’s request for a better solution, and rather than repurpose outdated tools and methods designed originally for other applications. They started a new and developed MMS from the ground up specifically with the protein scientist in mind.The company was founded in 2005 and is headquartered in Burlington, Massachusetts.

Biotechnology

Design

Electronics

Enterprise Software

RedShiftBio

David Sloan

Alan Opper

Eugene Ma

Tom Jump

The Engineering Team at RedShiftBio is responsible for designing, developing, and optimizing the Microfluidic Modulation Spectroscopy (MMS) platform. This team works collaboratively to innovate hardware and software solutions tailored for protein scientists, ensuring precision and efficiency in the biopharmaceutical development process. Each member contributes specialized expertise in mechanical, electrical, and software engineering to create and improve tools that measure critical protein structural changes, thereby supporting the efficacy and quality of drug products.

Engineering Team

Leadership Team

Engineering Team

About

Team members

Other teams at RedShiftBio

Leadership Team